Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - AZIYO BIOLOGICS, INC. | tm214229d1_ex32-2.htm |
| EX-32.1 - EXHIBIT 32.1 - AZIYO BIOLOGICS, INC. | tm214229d1_ex32-1.htm |
| EX-31.2 - EXHIBIT 31.2 - AZIYO BIOLOGICS, INC. | tm214229d1_ex31-2.htm |
| EX-31.1 - EXHIBIT 31.1 - AZIYO BIOLOGICS, INC. | tm214229d1_ex31-1.htm |
| EX-21.1 - EXHIBIT 21.1 - AZIYO BIOLOGICS, INC. | tm214229d1_ex21-1.htm |
| EX-4.4 - EXIBIT 4.4 - AZIYO BIOLOGICS, INC. | tm214229d1_ex4-4.htm |
| 10-K - FORM 10-K - AZIYO BIOLOGICS, INC. | tm214229d1_10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on Form S-8 (No. 333-249391) of Aziyo Biologics, Inc. of our report dated March 15, 2021 relating to the financial statements, which appears in this Annual Report on Form 10-K.
/s/ PricewaterhouseCoopers LLP
Baltimore, Maryland
March 15, 2021